Matthias Lehr
- Pharmacology top 2%
- Cannabis and Cannabinoid Research 20
- Inflammatory mediators and NSAID effects 9
- Physiology top 5%
- Adenosine and Purinergic Signaling 10
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis 7
- Biochemistry top 5%
- Organic Chemistry top 5%
- Synthesis and biological activity 7
-
- Protein Kinase Regulation and GTPase Signaling 36
- Enzyme function and inhibition 7
-
- Alcohol Consumption and Health Effects 7
- Co-authors
- Gerd DannhardtMichael HilgertS. S. ChatterjeeJochen KleinOksana WeichelHelga KöhlerMark A. HessAlexander Fuchs
- Cited by
- PharmacologyPhysiologyToxicology
- Partner nations
- GermanyUnited StatesFinland
In The Last Decade
Matthias Lehr
94 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 405
- Physiology 90
- Toxicology 64
- Biochemistry 95
- Organic Chemistry 328
Countries citing papers authored by Matthias Lehr
This map shows the geographic impact of Matthias Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Lehr more than expected).
Fields of papers citing papers by Matthias Lehr
This network shows the impact of papers produced by Matthias Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Lehr. The network helps show where Matthias Lehr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Lehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2018 | 7 | |
| 4 | 2018 | 7 | |
| 5 | 2017 | 15 | |
| 6 | 2016 | 9 | |
| 7 | 2016 | 6 | |
| 8 | 2014 | 17 | |
| 9 | 2013 | 30 | |
| 10 | 2011 | 14 | |
| 11 | 2009 | 25 | |
| 12 | 2009 | 35 | |
| 13 | 2008 | 31 | |
| 14 | 2007 | 22 | |
| 15 | 2006 | 29 | |
| 16 | 2005 | 5 | |
| 17 | 2004 | 22 | |
| 18 | 2002 | 7 | |
| 19 | 2001 | 13 | |
| 20 | 1996 | 7 |
About Matthias Lehr
Matthias Lehr is a scholar working on Physiology, Toxicology and Pharmacology, having authored 99 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (36 papers), Cannabis and Cannabinoid Research (20 papers), Adenosine and Purinergic Signaling (10 papers), Inflammatory mediators and NSAID effects (9 papers), Synthesis and biological activity (7 papers), Forensic Toxicology and Drug Analysis (7 papers), Enzyme function and inhibition (7 papers) and Alcohol Consumption and Health Effects (7 papers). The work is most often cited by research in Pharmacology (405 citations), Physiology (90 citations) and Toxicology (64 citations). Matthias Lehr has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Gerd Dannhardt, Michael Hilgert, S. S. Chatterjee, Jochen Klein, Oksana Weichel, Helga Köhler, Mark A. Hess, Alexander Fuchs, Uwe Koetter and Christa E. Müller.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.